CAVALLARO, Lucas Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 1.505
AS - Asia 1.137
EU - Europa 932
SA - Sud America 154
AF - Africa 69
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 1
Totale 3.804
Nazione #
US - Stati Uniti d'America 1.468
SG - Singapore 485
CN - Cina 393
DE - Germania 203
SE - Svezia 197
IE - Irlanda 187
BR - Brasile 119
IT - Italia 87
FI - Finlandia 85
HK - Hong Kong 72
VN - Vietnam 65
NL - Olanda 38
ZA - Sudafrica 37
TR - Turchia 35
GB - Regno Unito 28
IN - India 28
RU - Federazione Russa 23
CA - Canada 22
CI - Costa d'Avorio 21
FR - Francia 18
AR - Argentina 17
BD - Bangladesh 13
IR - Iran 12
MX - Messico 12
PL - Polonia 12
BE - Belgio 11
EC - Ecuador 8
ES - Italia 8
LT - Lituania 8
CZ - Repubblica Ceca 7
EU - Europa 6
AT - Austria 4
HU - Ungheria 4
ID - Indonesia 4
IQ - Iraq 4
UZ - Uzbekistan 4
IL - Israele 3
JP - Giappone 3
KG - Kirghizistan 3
MA - Marocco 3
RO - Romania 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
CO - Colombia 2
HR - Croazia 2
LV - Lettonia 2
PE - Perù 2
PK - Pakistan 2
PY - Paraguay 2
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MD - Moldavia 1
MU - Mauritius 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
UY - Uruguay 1
Totale 3.804
Città #
Chandler 307
Ashburn 266
Singapore 244
Dublin 175
Munich 164
Santa Clara 133
Beijing 81
Hong Kong 72
Helsinki 62
Nanjing 60
Dearborn 55
Shanghai 53
Dallas 45
Los Angeles 43
New York 40
Boardman 34
Johannesburg 34
Princeton 30
Izmir 28
Ho Chi Minh City 27
Ann Arbor 23
Abidjan 21
Turku 21
Buffalo 20
Parma 18
Frankfurt am Main 17
Wilmington 17
Moscow 15
Hefei 14
Pune 14
San Mateo 14
Nanchang 13
Shenyang 13
São Paulo 13
Tianjin 13
Changsha 11
London 11
Brussels 10
Hanoi 10
Toronto 10
Boston 9
Kunming 9
Jiaxing 8
Jinan 8
Warsaw 8
Columbus 7
Norwalk 7
Bremen 6
Denver 6
Hangzhou 6
Houston 6
Kocaeli 6
Phoenix 6
Chengdu 5
Chennai 5
Curitiba 5
Guangzhou 5
Hebei 5
Menlo Park 5
Seattle 5
Zanjan 5
Brooklyn 4
Cambridge 4
Haiphong 4
Hải Dương 4
Milan 4
Montreal 4
Ningbo 4
Nuremberg 4
Olomouc 4
Quito 4
Thái Bình 4
Thái Nguyên 4
Andover 3
Atlanta 3
Augusta 3
Bishkek 3
Brno 3
Chicago 3
Erbil 3
Frattamaggiore 3
Grafing 3
Marseille 3
Mexico City 3
Mumbai 3
Orem 3
Ottawa 3
Poplar 3
Rio Saliceto 3
Rome 3
Rostov-on-Don 3
Sacramento 3
Timisoara 3
Tokyo 3
Udine 3
Amsterdam 2
Bauru 2
Biên Hòa 2
Bologna 2
Budapest 2
Totale 2.507
Nome #
CS1.1 EFFICACY OF MESALAMINE AND THE ASSOCIATION OF MESALAMINE AND PROBIOTICS VERSUS RIFAXIMIN IN THE TREATMENT OF SYMPTOMATIC DIVERTICULAR DISEASE 255
Changes in surgical behaviors during the CoviD-19 pandemic. The SICE CLOUD19 Study 195
W1079 Curcumin Vs Domperidon in Functional Dyspepsia: Better the Prokinetic or An Agonist of Vanilloid Receptor? 144
Correction to: Changes in surgicaL behaviOrs dUring the CoviD-19 pandemic. The SICE CLOUD19 Study (Updates in Surgery, (2021), 73, 2, (731-744), 10.1007/s13304-021-01010-w) 143
710 Gastrin-17 (G-17): A Serological Bio-Marker for Diagnosis of Gastro-Esophageal Reflux Disease (GERD) 138
S1921 “GastroPanel Test” in the Clinical Outcome of GERD 126
Quality of life in uncomplicated diverticular disease: Is it another good reason for the treatment? 125
Serum pepsinogen II for early assessment of success of H. pylori eradication 125
INFLUENCE OF BMI ON GASTRIC ACID SECRETION IN ACID RELATED DISEASE 119
Does chronic hypercalcemia influence serum pepsinogens levels? 118
OC1.09.3 USEFULNESS OF GASTROPANEL FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASES 118
PA.28 SERUM PEPSINOGEN I AS NON INVASIVE MARKER OF GASTRIC ACID SECRETION 117
Gastro panel® for detection of atrophic gastritis: The “Parma model” 116
Esophagitis: acute therapy with omeprazole (Single Dosage Versus BID) 116
T1979 Pepsinogen II As Marker of Inflammation in H.P Infection and in NSAIDs Damage 115
Gastrin-17 (G-17) as a sensitive serological bio-marker for diagnosis of gastro-esophageal reflux disease (GERD) independently of H. pylori status 114
T1651 The Natural History of Gastric Ulcer: A Twenty-Four Years Clinical-Endoscopical Follow-Up 113
PA.6 GASTRIN-17 (G-17): A SEROLOGICAL BIO-MARKER FOR DIAGNOSIS OF GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD) 113
Clinical presentation of 324 patients with hepatocellular carcinoma (HCC) in a single center of North Italy 111
Gastroesophageal reflux disease in celiac patients: Preliminary results in 35 consecutive patients 111
OC3.07.1 CURCUMIN VS DOMPERIDON IN FUNCTIONAL DYSPEPSIA: BETTER THE PROKINETIC OR AN AGONIST OF VANILLOID RECEPTOR? 111
PA.27 GASTRO PANEL® FOR DETECTION OF ATROPHIC GASTRITIS: THE “PARMA MODEL” 109
PA.7 CLINICAL VARIABILITY IN THE PRESENTATION OF THE GASTROESOPHAGEAL REFLUX DISEASE BEFORE THE HP ERA (STUDY FROM 1975 TO 1995) 108
NOD2 and Crohn’s Disease Clinical Practice: From Epidemiology to Diagnosis and Therapy, Rewired 102
The THYCOVIT (Thyroid Surgery during COVID-19 pandemic in Italy) study: results from a nationwide, multicentric, case-controlled study 100
A new curcumin-based one week therapy for eradication of H. pylori infection 99
“GASTROPANEL TEST” IN THE CLINICAL OUTCOME OF GERD 98
PO.1 NERD AND ERD: THE SCENARIO IS CHANGING OVER THE TIME? A 30 YEARS FOLLOW UP STUDY 98
Cancro gastrico e Helicobacter pylori 96
Impact of the COVID-19 pandemic on surgery for thyroid cancer in Italy: nationwide retrospective study 92
Serum pepsinogen II and gastrin-17 as markers of NSAIDs gastropathy 90
La diagnosi sierologica delle gastriti croniche atrofiche 85
null 30
Totale 3.850
Categoria #
all - tutte 13.957
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.957


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202145 0 0 0 0 0 0 0 0 3 30 8 4
2021/2022244 7 11 1 44 29 6 12 11 10 15 32 66
2022/2023808 67 99 71 86 56 100 5 64 223 4 31 2
2023/2024279 11 19 5 6 21 68 23 32 10 17 36 31
2024/20251.087 37 39 43 58 126 132 59 63 179 70 92 189
2025/20261.005 231 119 154 209 279 13 0 0 0 0 0 0
Totale 3.850